Acceptability and Feasibility of Implementing a Coordinated Hospital/Non-hospital Parenting Support and Prevention Program for Families of Infants at High Neurodevelopmental Risk After Neonatal Intensive Care Hospitalization

Inclusion Criteria28

• WP1:
• For the group of parents of children with documented neurodevelopmental difficulties, their child must meet the following three conditions:
• Be between 18 months and 48 months corrected age at the time of the first focus group
• Have at least one risk factor putting them at high neurodevelopmental risk at birth:
• Preterm infant ≤ 31 WG + 6 days
• Birth weight less than 1500g
• Child who has had a stroke or stages 2 or 3 hypoxic-ischaemic encephalopathy of the newborn according to the Sarnat classification
• Central neurological lesion, diagnosed on brain imaging.
• Present an abnormal, non-transient clinical state: diagnosis of cerebral palsy made or in progress (GMFCS 1 to 5), central neurological syndrome, diagnosed neurodevelopmental disorder.
• The parents must be able to participate in the 3 interviews (T1, T2 and T3).
• For the group of infants at high neurodevelopmental risk at hospital discharge, their child must meet the following two conditions:
• Be between 34 weeks of amenorrhea (i.e., 1.5 months premature) and 12 months of corrected age at the time of the first focus group,
• Have at least one risk factor putting them at high neurodevelopmental risk at birth:
• Preterm infant ≤ 31 WG + 6 days
• Birth weight less than 1500g
• Child who has had a stroke or stages 2 or 3 hypoxic-ischaemic encephalopathy of the newborn according to the Sarnat classification
• Central neurological lesion, diagnosed on brain imaging.
• The parents must be able to participate in the 3 interviews (T1, T2 and T3).
• Professionals and parent support groups:
• Physiotherapists in private practice, labor and delivery nurses of the Maternal and Child Protection, CAMSP (psychomotricians, psychologists) and doctors involved in the care of children at developmental risk in charge of the follow-up of children for whom the parents have agreed to participate in the study. These professionals must in turn have agreed to participate in the study. User representatives (SOS Préma, Le Neurogroup...) who have agreed to participate in the study.
• WP2:
• Parents of children hospitalized in the neonatal services of the CHU Dijon who meet at least one of the following criteria:
• Be between 34 weeks of amenorrhea (1.5 months premature) and 3 months of corrected age (3 months post-term)
• Have at least one risk factor putting them at high neurodevelopmental risk at birth:
• Child who has had a stroke or stages 2 or 3 hypoxic-ischaemic encephalopathy of the newborn according to the Sarnat classification
• Central neurological lesion, diagnosed on brain imaging.
• Professionals:
• Physiotherapists in private practice, labor and delievery nurses of the Maternal and Child Protection, CAMSP (psychomotricians, psychologists) and physicians involved in the care of children at developmental risk in charge of the follow-up of the children whose parents agreed to participate in the study. These professionals must in turn have agreed to participate in the study.